pharma · Weight management · Short Bowel Syndrome
Zealand Pharma
Zealand Pharma A/S
Zealand Pharma clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Sydmarken 11, Søborg (Copenhagen), 2860, DK
- Founded
- 1998
- Employees
- 596
- Programs
- 18
- Drugs
- 20
- Patents
- 0
Zealand Pharma projects
5 ClinicalTrials.gov programs sponsored by Zealand Pharma.
Zealand Pharma has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Single and multiple ascending dose of ZP9830 in healthy participants
Zealand Pharma A/S
Autoimmune diseases
1 trial -
ZP7570-24026
Zealand Pharma A/S
Weight management
1 trial -
ZP8396-24059
Zealand Pharma A/S
Weight management
1 trial -
ZP8396-25041
Zealand Pharma A/S
Weight reduction
1 trial -
ZP8396-25077
Zealand Pharma A/S
Healthy / hepatic impaired volunteers only study to assess PK parameters
1 trial
Frequently asked questions
How many clinical projects does Zealand Pharma have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.